Back
DNA-repair ERCC1 Gene Polymorphisms in Epithelial Ovarian Cancer and Relation to Platinum Resistance and Survival
Karina Dahl Steffensen, Marianne Waldstrøm, Anders Jakobsen
J. Cancer Ther. Vol.2 No.2, June 29, 2011  DOI: 10.4236/jct.2011.22016
       (PDF  254K)     HTML     
The Predictive Value of Germline Polymorphisms in Patients with NSCLC
Anneli Nygaard, Karen-Lise Spindler, Christa Nyhus, Rikke Andersen, Anders Jakobsen
J. Cancer Ther. Vol.1 No.4, December 31, 2010  DOI: 10.4236/jct.2010.14034
       (PDF  155K)     HTML     
The Prognostic Importance of EGFR and COX-2 Expression in Cervix Cancer Stages IIb-IVa
Parvin Adimi, Karina Dahl Steffensen, Doris Schledermann, Eva Rye Rasmussen, Anders Jakobsen
J. Cancer Ther. Vol.2 No.1, March 08, 2011  DOI: 10.4236/jct.2011.21002
       (PDF  13987K)     HTML     
Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer—Results of a Phase II and Translational Research Study
Karen-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, John Ploen, Anders Jakobsen
J. Cancer Ther. Vol.4 No.6, July 05, 2013  DOI: 10.4236/jct.2013.46A2006
       (PDF  331K)     HTML     
The Prognostic Value of Cell-Free DNA in Advanced Non-Small-Cell Lung Cancer
Anneli Dowler Nygaard, Karen-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, Anders Jakobsen
J. Cancer Ther. Vol.4 No.8, August 13, 2013  DOI: 10.4236/jct.2013.48A001
       (PDF  170K)     HTML     
 
 
Top